Rational design, synthesis, and 2D-QSAR study of anti-oncological alkaloids against hepatoma and cervical carcinoma

Antitumor active dispiro[3H-indole-3,2′-pyrrolidine-3′,3′′-piperidine]-2(1H),4′′-diones 11–19 were regioselectively synthesized via azomethine ylide cycloaddition reactions with 3E,5E-1-alkyl-3,5-bis(arylmethylidene)-4-piperidones 3–7. Compounds 13, 14, and 16 reveal higher potency against the HeLa (cervical) tumor cell line than the standard reference cisplatin, while 11, and 12 seem more potent against the HepG2 (liver) carcinoma cell line relative to the standard reference doxorubicin hydrochloride as determined by in vitro Sulfo-Rhodamine-B bio-assay. 3D-Pharmacophores of the HeLa comprise five chemical features viz., two hydrogen bond acceptors, two hydrophobic centers and one positive ionizable center and HepG2 contains three chemical features viz., a hydrogen bond acceptor, a hydrophobic center and a positive ionizable center. These features of the tumor cell lines explain the variation of bioactivity relative to chemical structure. Statistically significant QSAR models describing the spiro-alkaloid bio-properties were obtained employing CODESSA-Pro software validating the observed pharmacological observations and identifying the most important parameters governing activity.

[1]  T. Hirai,et al.  Intraarterial Chemotherapy or Chemoembolization for Locally Advanced and/or Recurrent Hepatic Tumors: Evaluation of the Feeding Artery with an Interventional CT System , 2001, CardioVascular and Interventional Radiology.

[2]  Aladdin M. Srour,et al.  Microwave assisted synthesis and QSAR study of novel NSAID acetaminophen conjugates with amino acid linkers. , 2014, Organic & biomolecular chemistry.

[3]  A. S. Girgis,et al.  Facile synthesis, vasorelaxant properties and molecular modeling studies of 2-amino-8a-methoxy-4H-pyrano[3,2-c]pyridine-3-carbonitriles. , 2011, European journal of medicinal chemistry.

[4]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[5]  Iva B. Stoyanova-Slavova,et al.  QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents. , 2010, European journal of medicinal chemistry.

[6]  R. Grigg,et al.  Decarboxylative transamination. Mechanism and applications to the synthesis of heterocyclic compounds , 1984 .

[7]  Ghada S. Hassan,et al.  Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues. , 2012, European journal of medicinal chemistry.

[8]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[9]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[10]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[11]  Riham F. George,et al.  Design, synthesis and QSAR studies of dispiroindole derivatives as new antiproliferative agents. , 2013, European journal of medicinal chemistry.

[12]  A. S. Girgis Regioselective synthesis and stereochemical structure of anti-tumor active dispiro[3H-indole-3,2'-pyrrolidine-3',3''-piperidine]-2(1H),4''-diones. , 2009, European journal of medicinal chemistry.

[13]  Zuhong Lu,et al.  The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles. , 2014, Gene.

[14]  A. S. Girgis,et al.  Synthesis and QSAR study of novel cytotoxic spiro[3H-indole-3,2'(1'H)-pyrrolo[3,4-c]pyrrole]-2,3',5'(1H,2'aH,4'H)-triones. , 2012, European journal of medicinal chemistry.

[15]  C. Mai,et al.  Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins. , 2014, European journal of medicinal chemistry.

[16]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[17]  A. S. Girgis,et al.  Novel synthesis of nicotinamide derivatives of cytotoxic properties. , 2006, Bioorganic & medicinal chemistry.

[18]  S. Barni,et al.  A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. , 2014, Gynecologic oncology.

[19]  G. Liang,et al.  Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents. , 2013, Bioorganic & medicinal chemistry.

[20]  M. Irahara,et al.  Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy. , 2012, Oncology letters.

[21]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[22]  E. Tiekink,et al.  1′-Methyl-4′-(4-methylphenyl)dispiro[indane-2,3′-pyrrolidine-2′,3′′-indoline]-1,2′′-dione , 2012, Acta crystallographica. Section E, Structure reports online.

[23]  Shireen S. Rajaram,et al.  A review of global cancer burden: Trends, challenges, strategies, and a role for surgeons , 2013, Journal of surgical oncology.

[24]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[25]  A. Sasco,et al.  The growing incidence of cancer: role of lifestyle and screening detection (Review). , 2007, International journal of oncology.

[26]  Bhuvanesh Singh,et al.  Comprehensive molecular cytogenetic characterization of cervical cancer cell lines , 2003, Genes, chromosomes & cancer.

[27]  K. Straif,et al.  Carcinogenicity of human papillomaviruses. , 2005, The Lancet. Oncology.

[28]  M. Banerjee,et al.  Association of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian population. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[29]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[30]  G. Sheldrick A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[31]  ElSayed M Shalaby,et al.  Regioselective synthesis, stereochemical structure, spectroscopic characterization and geometry optimization of dispiro[3H-indole-3,2′-pyrrolidine-3′,3″-piperidines] , 2014 .

[32]  T. Kasamatsu,et al.  Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer. , 2014, Gynecologic oncology.

[33]  E. D. de Vries,et al.  Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. , 2003, Cancer treatment reviews.

[34]  H. Frankish 15 million new cancer cases per year by 2020, says WHO , 2003, The Lancet.

[35]  P. Rose,et al.  Management of locally advanced cervical cancer , 2005, Current opinion in oncology.

[36]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[37]  C. Mandal,et al.  Improved chemosensitivity in cervical cancer to cisplatin: synergistic activity of mahanine through STAT3 inhibition. , 2014, Cancer letters.

[38]  Donghong Wang,et al.  Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[40]  A. Katritzky,et al.  Regioselective synthesis and molecular modeling study of vasorelaxant active 7,9-dioxa-1,2-diaza-spiro[4.5]dec-2-ene-6,10-diones. , 2010, European journal of medicinal chemistry.

[41]  M. Mansukhani,et al.  Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression , 2008, Genes, chromosomes & cancer.

[42]  D. Alberts,et al.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  A. S. Girgis Regioselective synthesis of dispiro[1H-indene-2,3'-pyrrolidine-2',3''-[3H]indole]-1,2''(1''H)-diones of potential anti-tumor properties. , 2009, European journal of medicinal chemistry.

[44]  R. Burk,et al.  Human papillomavirus genome variants. , 2013, Virology.

[45]  J. Howard,et al.  Synthesis and spectroscopic and structural studies of cross-conjugated dienones derived from cyclic ketones and aromatic aldehydes , 2006 .

[46]  Riham F. George,et al.  Synthesis, hypnotic properties and molecular modeling studies of 1,2,7,9-tetraaza-spiro[4.5]dec-2-ene-6,8,10-triones. , 2011, European journal of medicinal chemistry.

[47]  A. Gadducci,et al.  Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study. , 2014, Gynecologic oncology.

[48]  A. S. Girgis,et al.  Synthetic approaches towards bisspiro[naphthalene-2(1H),3′-(3H)pyrazol]-1-one-containing compounds , 2006 .

[49]  J. Medina-Franco,et al.  Traceless solid-phase synthesis of N-substituted 3,5-bis(substituted-idene)piperidin-4-one derivatives , 2010 .

[50]  W. Park,et al.  EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells. , 2014, Cancer letters.

[51]  Girinath G. Pillai,et al.  Synthesis, and QSAR analysis of anti-oncological active spiro-alkaloids. , 2015, Organic & biomolecular chemistry.

[52]  A. Dueñas-González,et al.  Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  A. Katritzky,et al.  Regioselective synthesis and theoretical studies of an anti-neoplastic fluoro-substituted dispiro-oxindole , 2015 .

[54]  P. Álvarez,et al.  Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo. , 2014, European journal of medicinal chemistry.

[55]  Vikas Verma,et al.  Design, regioselective synthesis and cytotoxic evaluation of 2-aminoimidazole-quinoline hybrids against cancer and primary endothelial cells. , 2014, European journal of medicinal chemistry.

[56]  J. Bruix,et al.  Management of HCC. , 2012, Journal of hepatology.